Drug class
Ophthalmic Antibacterials
Ophthalmic antibacterials are a therapeutic class of topical antimicrobial medications formulated as sterile eye drops or ointments to treat or prevent localized bacterial infections of the eye and ocular adnexa. Read more about Ophthalmic Antibacterials
182 drugs in this class 57 manufacturers
Drugs in Ophthalmic Antibacterials
TOBRAMYCIN-LOTEPREDNOL (tobramycin/loteprednol etabonate)
TOBRAMYCIN-LOTEPREDNOL (tobramycin/loteprednol etabonate)
OFLOXACIN
TOBRADEX (tobramycin/dexamethasone)
TOBREX (tobramycin)
VANCOMYCIN (vancomycin HCl in sterile water)
ERYTHROMYCIN (erythromycin base)
TOBRAMYCIN-DEXAMETHASONE (tobramycin/dexamethasone)
Ophthalmic antibacterials are a therapeutic class of topical antimicrobial medications formulated as sterile eye drops or ointments to treat or prevent localized bacterial infections of the eye and ocular adnexa.
This broad pharmacological category encompasses multiple antibiotic drug families, including fluoroquinolones, aminoglycosides, macrolides, and polymyxin combinations, which exert bactericidal or bacteriostatic effects by inhibiting bacterial cell wall synthesis, protein translation, or nucleic acid replication.
Clinically, these agents are primarily indicated for superficial and anterior segment conditions such as bacterial conjunctivitis, blepharitis, and bacterial keratitis, as well as for perioperative prophylaxis during ocular procedures.
-
fda.gov
Ophthalmic antibacterials are a therapeutic class of topical antimicrobial medications formulated as sterile eye drops or ointments to treat or prevent localized bacterial infections of the eye and ocular adnexa This broad pharmacological category encompasses multiple antibiotic drug families, including fluoroquinolones, aminoglycosides, macrolides, and polymyxin combinations, which exert bactericidal or bacteriostatic effects by inhibiting bacterial cell wall synthesis, protein translation, or ...
-
nv.gov
Ophthalmic antibacterials are a therapeutic class of topical antimicrobial medications formulated as sterile eye drops or ointments to treat or prevent localized bacterial infections of the eye and ocular adnexa This broad pharmacological category encompasses multiple antibiotic drug families, including fluoroquinolones, aminoglycosides, macrolides, and polymyxin combinations, which exert bactericidal or bacteriostatic effects by inhibiting bacterial cell wall synthesis, protein translation, or ...
-
fda.gov
This broad pharmacological category encompasses multiple antibiotic drug families, including fluoroquinolones, aminoglycosides, macrolides, and polymyxin combinations, which exert bactericidal or bacteriostatic effects by inhibiting bacterial cell wall synthesis, protein translation, or nucleic acid replication
-
nih.gov
This broad pharmacological category encompasses multiple antibiotic drug families, including fluoroquinolones, aminoglycosides, macrolides, and polymyxin combinations, which exert bactericidal or bacteriostatic effects by inhibiting bacterial cell wall synthesis, protein translation, or nucleic acid replication
-
medlineplus.gov
Clinically, these agents are primarily indicated for superficial and anterior segment conditions such as bacterial conjunctivitis, blepharitis, and bacterial keratitis, as well as for perioperative prophylaxis during ocular procedures
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.